Buy alert! Broker says this ASX 200 share can rise 30%+

Big returns could be on offer from this blue chip according to Bell Potter.

| More on:
A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now could be the time to load up on Challenger Ltd (ASX: CGF) shares.

That's the view of analysts at Bell Potter, which have just initiated coverage on the ASX 200 share.

What is the broker saying about this ASX 200 share?

Bell Potter believes that the annuities company is well-placed to benefit from Australia's ageing population. It said:

CGF is focused on providing financial security for retirement. It is therefore well placed for an ageing population, with products for those accumulating in the approach to retirement, and those decumulating in retirement. This is supported by the growth in the superannuation system, which is expected to grow from $3.9trn currently to $11trn over the next 20 years.

Big return potential

In light of its positive outlook and attractive valuation, the broker has initiated coverage on the ASX 200 stock with a buy rating and $8.25 price target.

Based on the latest Challenger share price of $6.25, this implies potential upside of 32% for investors over the next 12 months.

In addition, its analysts are forecasting fully franked dividend yields of 4.8% in FY 2025 and 5.1% in FY 2026. This stretches the total potential 12-month return to almost 37%.

Bell Potter explained that there are five key points backing up its buy recommendation. It said:

Our buy case is predicated the recent increase in sales of lifetime annuities and resultant stronger growth in the life book. We make the following five points.

1/ We believe the most important products that CGF writes are lifetime annuities. 2/ Precovid, lifetime annuities sales averaged over $200m per quarter and represented about 20% of life sales. As a result, net flows into the life book ran at over 10% per year. 3/ in FY20, the impact of Covid-19 and low interest rates reduced the attraction of lifetime annuities and sales averaged $120m per quarter, and net flows slowed to low single digit.

4/ In FY21 and FY22 CGF grew by selling shorter term annuities, although as these matured after 1-2 years, the growth of the book slowed back down to mid-single digit. 5/ Lifetime sales picked up in 2023 and are running above $200m per quarter, rising to $275m in Q1 FY25. We estimate that the market is expecting the life book to continue to grow at mid-single digits, but as lifetime annuity sales pick up, we believe the book will revert to growing at high-single or low-double digit.

Should you invest $1,000 in Australian Foundation Investment Company Limited right now?

Before you buy Australian Foundation Investment Company Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Australian Foundation Investment Company Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Business people discussing project on digital tablet.
Materials Shares

What does Macquarie think Liontown Resources shares are worth?

Let's see if analysts think that this lithium miner is in the buy zone or best avoided.

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

What does Macquarie think ResMed shares are worth?

Does the broker see value in this blue chip? Let's find out.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 30% to 70%

Let's see which shares analysts are tipping to generate big returns.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man working in the stock exchange.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Broker Notes

10 best shares to buy today in Australia

Analysts think these shares are among the best to buy now.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Financial Shares

This leading broker just upgraded AMP shares to 'outperform'. Here's why

This top broker just turned bullish on AMP shares. But why?

Read more »